PL418202A1 - Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika - Google Patents
Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnikaInfo
- Publication number
- PL418202A1 PL418202A1 PL418202A PL41820216A PL418202A1 PL 418202 A1 PL418202 A1 PL 418202A1 PL 418202 A PL418202 A PL 418202A PL 41820216 A PL41820216 A PL 41820216A PL 418202 A1 PL418202 A1 PL 418202A1
- Authority
- PL
- Poland
- Prior art keywords
- lymphocytes
- phenotype
- solution
- foxp3
- inducing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 8
- 210000004698 lymphocyte Anatomy 0.000 title abstract 7
- 102000004169 proteins and genes Human genes 0.000 title abstract 6
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 title abstract 5
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 title abstract 5
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 title abstract 5
- 230000001939 inductive effect Effects 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 244000045947 parasite Species 0.000 title abstract 2
- 244000000013 helminth Species 0.000 title 1
- 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 2
- 230000000392 somatic effect Effects 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 102100027581 Forkhead box protein P3 Human genes 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 210000000601 blood cell Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4642—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
Abstract
Przedmiotem zgłoszenia jest sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+, w którym izolowane komórki krwi osobnika, kontaktuje się ex vivo z roztworem białek somatycznych i/lub wydalniczo - wydzielniczych z pasożyta z grupy helmintów i/lub z funkcyjnymi frakcjami białkowymi z wymienionego roztworu i/lub z rekombinowanymi białkami o sekwencji aminokwasowej identycznej w przynajmniej 70% z białkami wymienionego roztworu zachowującymi aktywność białek wymienionego roztworu, przy czym uzyskane indukowane limfocyty o fenotypie CD8+CD25+ nie wykazują ekspresji czynnika transkrypcyjnego FOXP3. Zgłoszenie dotyczy też limfocytów uzyskanych wymienionym sposobem do zastosowania w sposobach zapobiegania i leczenia chorób związanych z obecnością autoreaktywnych limfocytów T, w szczególności chorób autoimmunizacyjnych, a także roztworu białek somatycznych i wydalniczo - wydzielniczych z pasożyta z grupy helmintów i/lub funkcyjnych frakcji białkowych z wymienionego roztworu i/lub rekombinowanych białek do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3- u potrzebującego tego osobnika.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL418202A PL418202A1 (pl) | 2016-08-04 | 2016-08-04 | Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika |
EP17772758.3A EP3493835B1 (en) | 2016-08-04 | 2017-08-04 | Method for ex vivo induction of suppressor lymphocytes using a solution of proteins from helminth parasites |
FIEP17772758.3T FI3493835T3 (fi) | 2016-08-04 | 2017-08-04 | Menetelmä suppressorilymfosyyttien ex vivo -induktioon käyttämällä loismadoista peräisin olevaa proteiiniliuosta |
PCT/IB2017/054790 WO2018025236A1 (en) | 2016-08-04 | 2017-08-04 | Method for ex vivo induction of suppressor lymphocytes using a solution of proteins from helminth parasites, lymphocytes produced by this method and uses thereof |
PL17772758.3T PL3493835T3 (pl) | 2016-08-04 | 2017-08-04 | Sposób indukowania ex vivo limfocytów supresorowych roztworem białek z pasożyta z grupy helmintów |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL418202A PL418202A1 (pl) | 2016-08-04 | 2016-08-04 | Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika |
Publications (1)
Publication Number | Publication Date |
---|---|
PL418202A1 true PL418202A1 (pl) | 2018-02-12 |
Family
ID=59969189
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL418202A PL418202A1 (pl) | 2016-08-04 | 2016-08-04 | Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika |
PL17772758.3T PL3493835T3 (pl) | 2016-08-04 | 2017-08-04 | Sposób indukowania ex vivo limfocytów supresorowych roztworem białek z pasożyta z grupy helmintów |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL17772758.3T PL3493835T3 (pl) | 2016-08-04 | 2017-08-04 | Sposób indukowania ex vivo limfocytów supresorowych roztworem białek z pasożyta z grupy helmintów |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3493835B1 (pl) |
FI (1) | FI3493835T3 (pl) |
PL (2) | PL418202A1 (pl) |
WO (1) | WO2018025236A1 (pl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3773640A1 (en) * | 2018-04-05 | 2021-02-17 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Larval preparation of heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050118655A1 (en) * | 2003-11-17 | 2005-06-02 | University Of Iowa Research Foundation | Use of parasitic biological agents for diseases prevention and control |
WO2013039872A1 (en) * | 2011-09-12 | 2013-03-21 | Tufts Medical Center | Compositions and methods for treating inflammatory bowel diseases |
WO2013192215A1 (en) * | 2012-06-18 | 2013-12-27 | Yale University | Compositions and methods for diminishing an immune response |
-
2016
- 2016-08-04 PL PL418202A patent/PL418202A1/pl unknown
-
2017
- 2017-08-04 FI FIEP17772758.3T patent/FI3493835T3/fi active
- 2017-08-04 EP EP17772758.3A patent/EP3493835B1/en active Active
- 2017-08-04 PL PL17772758.3T patent/PL3493835T3/pl unknown
- 2017-08-04 WO PCT/IB2017/054790 patent/WO2018025236A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3493835A1 (en) | 2019-06-12 |
FI3493835T3 (fi) | 2023-09-20 |
WO2018025236A1 (en) | 2018-02-08 |
PL3493835T3 (pl) | 2024-02-12 |
EP3493835B1 (en) | 2023-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Koay et al. | A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage | |
CL2019003390A1 (es) | Proteínas de anticuerpo injertadas con citocina y métodos de uso en el tratamiento del cáncer | |
BR112017018224A2 (pt) | métodos para manipulação de célula t alogênica para aumentar sua persistência e/ou implante em pacientes | |
BR112017019140A2 (pt) | métodos de tratamento de câncer usando células t ativadas | |
Hernández-Malmierca et al. | Antigen presentation safeguards the integrity of the hematopoietic stem cell pool | |
BR112013026114A2 (pt) | composições nutricionais que incluem ácidos graxos de cadeia ramificada e processos de utilização das mesmas | |
Abu Kasim et al. | Unique molecular signatures influencing the biological function and fate of post‐natal stem cells isolated from different sources | |
EP3943092A3 (en) | Compositions for use in inducing differentiation of human brown adipocyte progenitors | |
AR102538A1 (es) | Métodos de selección de la línea celular t y donante de la misma para la terapia adoptiva celular | |
MX2016010923A (es) | Metodo para generar celulas t compatibles para el trasplante alogenico. | |
GB2562406A (en) | A method of non destructive monitoring of biological processes in microfluidic tissue culture systems | |
MX2018000293A (es) | Analisis genealogico y genetico para identificacion de informacion de apellidos y lugar de nacimiento. | |
BR112013018744A2 (pt) | método para produzir um polipetídeo ou uma proteína recombinante | |
BR112018067536A2 (pt) | sistema de transpóson e métodos de uso | |
CU24405B1 (es) | Proteínas de variantes de secuencias de aminoácidos de cry1da1 activas para lepidópteros | |
BR112016016525A2 (pt) | Método para indução de células treg (ctla-4+, cd4+, cd25+) foxp3+ e/ou células treg lap+ em um indivíduo, método para melhorar uma condição em um indivíduo, e método para a produção de células treg (ctla-4+, cd4+, cd25+) foxp3+ e/ou células treg lap+ | |
BR112014023642A2 (pt) | proteína interferon-lambda4 (ifnl4), moléculas de anticorpo relacionadas, e usos das mesmas | |
MX2022010954A (es) | Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. | |
Webb et al. | Non-binary gender identities | |
PL418202A1 (pl) | Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika | |
AR109279A1 (es) | Anticuerpos anti plazomicina y métodos de uso de los mismos | |
Zheng et al. | Biological effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro | |
MX2021000853A (es) | Vacunas individualizadas para el cancer. | |
MX2019010829A (es) | Metodos y composiciones para suministrar agentes activos de acido micofenolico a mamiferos no humanos. | |
Stepanova et al. | The combined treatment of dysphonia in the subjects engaged in the voice and speech professions |